Literature DB >> 20435093

Epilepsy and serotonin (5HT): variations of 5HT-related genes in temporal lobe epilepsy.

Jasminka Stefulj1, Tatjana Bordukalo-Niksic, Hrvoje Hecimovic, Vida Demarin, Branimir Jernej.   

Abstract

Several lines of evidence point to the role of serotonin (5HT) neurotransmission in the epileptogenesis. The present preliminary study investigated possible association of the temporal lobe epilepsy (TLE) with the polymorphisms in several 5HT-related genes, including serotonin transporter (5HTT), monoamine oxidase A (MAO-A) and serotonin receptors 5HT-1A, 5HT-1B and 5HT-2C. All participants (101 TLE patients and 170 healthy controls) were unrelated individuals of Croatian origin. 5HT-1B allele 861G was found to be slightly overrepresented in the patient group (p=0.0385). No significant differences between groups were observed for the other tested polymorphisms. Within the limitations imposed by the size of our sample, negative findings suggest that the respective loci do not make considerable contribution to the etiopathogenesis of TLE. Further examination of 5HT-1B gene, which yielded positive result at a trend level, is possibly warranted. (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435093     DOI: 10.1016/j.neulet.2010.04.060

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy.

Authors:  Rita Citraro; Antonio Leo; Pasquale De Fazio; Giovambattista De Sarro; Emilio Russo
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

2.  SLC6A4 gene variants and temporal lobe epilepsy susceptibility: a meta-analysis.

Authors:  Marta Córdoba; Damián Consalvo; Dolores Gonzalez Moron; Silvia Kochen; Marcelo Andrés Kauffman
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

Review 3.  Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.

Authors:  Martin J Brodie; Frank Besag; Alan B Ettinger; Marco Mula; Gabriella Gobbi; Stefano Comai; Albert P Aldenkamp; Bernhard J Steinhoff
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

4.  The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy.

Authors:  Ashley Martinez; Andrey Finegersh; Dara M Cannon; Irene Dustin; Alison Nugent; Peter Herscovitch; William H Theodore
Journal:  Neurology       Date:  2013-03-20       Impact factor: 9.910

5.  Genetics of temporal lobe epilepsy: a review.

Authors:  Annick Salzmann; Alain Malafosse
Journal:  Epilepsy Res Treat       Date:  2012-02-19

Review 6.  Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Authors:  Dubravka Svob Strac; Nela Pivac; Ilse J Smolders; Wieslawa A Fogel; Philippe De Deurwaerdere; Giuseppe Di Giovanni
Journal:  Front Neurosci       Date:  2016-11-10       Impact factor: 4.677

7.  Methylation of BDNF and SLC6A4 Gene Promoters in Brazilian Patients With Temporal Lobe Epilepsy Presenting or Not Psychiatric Comorbidities.

Authors:  Isabel Cristina Bandeira; Lucas Giombelli; Isabel Cristina Werlang; Ana Lucia Abujamra; Thais Leite Secchi; Rosane Brondani; José Augusto Bragatti; Jorge Wladimir Junqueira Bizzi; Sandra Leistner-Segal; Marino Muxfeldt Bianchin
Journal:  Front Integr Neurosci       Date:  2021-11-29

8.  A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders.

Authors:  Roselyn Rose'meyer
Journal:  Mol Autism       Date:  2013-10-08       Impact factor: 7.509

Review 9.  Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment.

Authors:  Sarita Thakran; Debleena Guin; Pooja Singh; Priyanka Singh; Samiksha Kukal; Chitra Rawat; Saroj Yadav; Suman S Kushwaha; Achal K Srivastava; Yasha Hasija; Luciano Saso; Srinivasan Ramachandran; Ritushree Kukreti
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.